POST-COVID ME/CFS

Clinical trials for POST-COVID ME/CFS explained in plain language.

Never miss a new study

Get alerted when new POST-COVID ME/CFS trials appear

Sign up with your email to follow new studies for POST-COVID ME/CFS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1 Completed 1

Heart drug trial offers hope for long COVID sufferers

Symptom relief Ongoing

This study is testing whether a drug called vericiguat, already approved for heart failure, can help people with Long COVID. It aims to see if the drug can improve their ability to do daily activities and reduce severe fatigue. About 104 adults aged 18-50 with Long COVID symptoms…

Matched conditions: POST-COVID ME/CFS

Phase: PHASE2 • Sponsor: Charite University, Berlin, Germany • Aim: Symptom relief

Last updated Mar 30, 2026 14:34 UTC

POST-COVID ME/CFS

Get alerted when new POST-COVID ME/CFS trials appear

Heart drug trial offers hope for long COVID sufferers